There are 203 resources available
Welcome to the ESMO TAT Congress 2025 by the Scientific Co-Chairs
Presenter: Elena Garralda, Cristian Massacesi, Anastasios Stathis
Session: Opening session and 2025 TAT Honorary Award
Resources:
Slides
Webcast
Introduction to the 2025 TAT Honorary Awardee
Presenter: Elena Garralda
Session: Opening session and 2025 TAT Honorary Award
Resources:
Slides
Webcast
Bridging cancer genomics and drug development: An academic perspective
Presenter: Philippe Bedard
Session: Opening session and 2025 TAT Honorary Award
Resources:
Slides
Webcast
Early clinical strategies and Project Optimus considerations for novel-novel drug combinations
Presenter: Timothy Anthony Yap
Session: Novel combinations in molecular oncology: Bench to bedside to the regulator
Resources:
Slides
Webcast
Regulatory perspectives and considerations for novel combination drug approval
Presenter: Sinan Sarac
Session: Novel combinations in molecular oncology: Bench to bedside to the regulator
Resources:
Slides
Webcast
Panel discussion
Session: Novel combinations in molecular oncology: Bench to bedside to the regulator
Resources:
Webcast
7O - Trastuzumab deruxtecan (T-DXd) ± pertuzumab (P) in previously untreated HER2+ metastatic breast cancer (mBC): Clinical efficacy and exploratory subgroup analyses in DESTINY-Breast07
Presenter: Fabrice André
Session: Oral abstract session 1
Resources:
Abstract
Slides
Webcast
8O - First-line (1L) datopotamab deruxtecan (Dato-DXd) + durvalumab ± carboplatin in advanced or metastatic non-small cell lung cancer (a/mNSCLC): Results from TROPION-Lung04 (cohorts 2 and 4)
Presenter: Ewa Kalinka
Session: Oral abstract session 1
Resources:
Abstract
Slides
Webcast
Invited Discussant 7O and 8O
Presenter: Giuseppe Curigliano
Session: Oral abstract session 1
Resources:
Slides
Webcast
Q&A and discussion
Session: Oral abstract session 1
Resources:
Webcast